Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

2.64
+0.240010.00%
Post-market: 2.650.0100+0.38%18:59 EDT
Volume:3.41M
Turnover:8.89M
Market Cap:415.92M
PE:5.44
High:2.71
Open:2.46
Low:2.43
Close:2.40
Loading ...
Jul 25, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 13, 2022

Major Issues Report

8-K - Current report
Jul 06, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2022

Major Issues Report

8-K - Current report
Apr 14, 2022

Major Issues Report

8-K - Current report
Mar 23, 2022

Major Issues Report

8-K - Current report
Mar 04, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Major Issues Report

8-K - Current report
Feb 01, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 03, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals